Diabetes
5 new AI features in iOS 27.3's Health app – which iPhones can try them
Our gifting experts are obsessively searching for holiday gifts that are unique, thoughtful and suitable for any budget. Apple's redesigned Health app arrives in December with some major upgrades, but not every iPhone will get the full experience. Lance Whitney is a technology journalist with an IT background. He's written for TechRepublic, PCMag, Macworld, and Time, among others, He also teaches classes in AI, cybersecurity, and social media. Apple is launching a new Health app in December with iOS 27.3.
Why this new Fitbit feature takes us one step closer to non-invasive glucose tracking
Our gifting experts are obsessively searching for holiday gifts that are unique, thoughtful and suitable for any budget. Insulin resistance and blood pressure trends are now available on two new Fitbit devices. Nina Raemont is ZDNET's Health and Wearables Editor based in New York City. Insulin resistance and blood pressure trends are coming to the Fitbit Air and Fitbit Edge. These new features are available for Google Health Premium users only.
A New Anti-Aging Drug Looks to Turn Back the Clock on Skin Age
After four weeks of using the cream, participants lowered the biological age of their skin by about two years on average. A wave of biotech companies is looking to prove that it's possible to slow down the aging process. Mountain View, California-based Rubedo Life Sciences is starting with the most outwardly visible sign: the skin. The company's experimental treatment is showing early promise that it may be able to reduce the appearance of aging, according to data the company presented at the Aging Research and Drug Discovery meeting in Boston earlier this month. In a small clinical trial, Rubedo tested its topical cream on 11 people with atopic dermatitis, an inflammatory skin condition and the most common type of eczema.
Measles Is Forcing Hospitals to Adapt to a New Normal
The US resurgence of measles is forcing hospitals and health systems to adopt new protocols and procedures to deal with a disease they thought was in the past. John Goldman had not seen a case of measles in 30 years. But since April, the infectious disease specialist with the University of Pittsburgh Medical Center in central Pennsylvania has had dozens of patients come down with the disease. "I never thought I would see this come back," he says. His health system, like others, has had to adapt to a new normal as measles makes a comeback in the United States.
A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a "moral imperative" to address hereditary diseases. When the Chinese scientist He Jiankui announced in 2018 that he had created the first gene-edited babies, the experiment was widely condemned as reckless and premature. It ended with He in prison. But that hasn't stopped the push for gene-edited human embryos, with biotech entrepreneur Cathy Tie arguing that doing so isn't just urgent--it's a "moral imperative." Tie is the 30-year-old founder of Origin Genomics, a company that launched in March with plans to bring gene-edited embryos to IVF clinics.
Robert Waldinger Knows the Secret to a Happy Life
Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Dr. Robert Waldinger didn't believe it at first. The idea that loneliness could break down the body--that the quality of your relationships might help decide whether you get coronary artery disease, arthritis, or Type 2 diabetes--struck the psychiatrist as far-fetched.
Abbott partners with Google Health for AI-powered glucose monitoring
Health care company Abbott has entered into a partnership to connect Google Health to its Lingo continuous glucose monitor (CGM). According to the press release, this multi-year collaboration will allow users of the over-the-counter Lingo device to see their metabolic data within the Google Health app, which could help a person "make better lifestyle and nutrition choices in the moment." The Lingo data can also be shared with the Google Health Coach, which offers AI-driven recommendations based on an individual's information. Lingo is explicitly intended for adults who are not using insulin. Engadget reported on the growing trend of non-diabetics using continuous glucose monitors back in 2023 and found little research that supported the benefits for that population to track blood sugar spikes so closely.